CRISPR/Cas9 Genetic Modification of CYP3A5 *3 in HuH-7 Human Hepatocyte Cell Line Leads to Cell Lines with Increased Midazolam and Tacrolimus Metabolism

Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 engineering of the CYP3A5 *3 locus (rs776746) in human liver cell line HuH-7 (CYP3A5 *3/*3) has led to three CYP3A5 *1 cell lines by deletion of the exon 3B splice junction or point mutation. Cell lines CYP3A5 *1/*3 sd (single d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Drug Metab Dispos
Autors principals: Dorr, Casey R., Remmel, Rory P., Muthusamy, Amutha, Fisher, James, Moriarity, Branden S., Yasuda, Kazuto, Wu, Baolin, Guan, Weihua, Schuetz, Erin G., Oetting, William S., Jacobson, Pamala A., Israni, Ajay K.
Format: Artigo
Idioma:Inglês
Publicat: The American Society for Pharmacology and Experimental Therapeutics 2017
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5518718/
https://ncbi.nlm.nih.gov/pubmed/28533324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/dmd.117.076307
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars